BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Breaking News: Read BioWorld's AACR 2026 coverageBreaking News: Best of BioWorld: Q1
Home » Topics » BioWorld

BioWorld
BioWorld RSS Feed RSS

Handshake with DNA, molecules

Senti enters a $645M deal with Spark

April 13, 2021
By Anette Breindl and Lee Landenberger
Senti Biosciences Inc. stands to receive more than $645 million in up-front, opt-in and milestone payments through a new collaboration and option agreement with Spark Therapeutics Inc.
Read More

Aspirin to greatness in cardio, Plx readies liquid Vazalore launch

April 13, 2021
By Randy Osborne
Plx Pharma Inc. is not letting out the details just yet about next quarter’s launch of liquid-filled aspirin capsule Vazalore, recently cleared by the FDA in 81-mg and 325-mg doses, but CEO Natasha Giordano said cardiologists are “essential to our strategy. We have developed very deep sales plans [that are] laser-focused.”
Read More

Regulatory actions for April 13, 2021

April 13, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akouos, Avenue, Axcella Health, Celularity, Janssen, Kibow, Lintonpharm, Neuraptive, Novartis, RDIF, Vtv.
Read More

Other news to note for April 13, 2021

April 13, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 9 Meters, Actimed, AGTC, Akers, Aytu, Biomica, BMS, Bridgebio, Cybin, Denovo, Evogene, Evotec, Eyam, Faraday, Intravacc, Kiadis, Merck KGaA, Mymd, Nkgen, Philogen, Rumpus, Sanofi, Teamedon, Therapeutic Solutions.
Read More

In the clinic for April 13, 2021

April 13, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adagio, Akari, Apellis, Atriva, Bausch + Lomb, Boehringer, Cardiol, Epiendo, Geron, Iterion, Kinarus, Lindis, Longeveron, Mei, Merck, Nasus, Otsuka, Peptilogics, Prexa Sante, Rigel, Synlogic, Vallon, Valneva.
Read More

Financings for April 13, 2021

April 13, 2021
Biopharmas raising money in public or private financings, including: Arcellx, Briacell, Cerevel, Crinetics, GH, Jaguar, Onxeo, Recursion, Repertoire, Xoma.
Read More

Conference data for April 13, 2021: AACR

April 13, 2021
New and updated preclinical and clinical data presented by biopharma firms at the American Association for Cancer Research Annual Meeting 2021, including: BMS, Kronos, Kymera, Medicenna, Medigene, Mei, Mersana, Mirati, Molecular Partners, Molecular Templates, Morphic, Nextcure, Nuvalent, Oasmia, Oncolytics, Oncomyx, Oncurious, Oncternal, Oric, Pharmabcine, Phio, Pieris, PMV, Puretech, Schrodinger, Seneca.
Read More

Appointments and advancements for April 13, 2021

April 13, 2021
New hires and promotions in the biopharma industry, including: Aavantibio, Adicet, Albireo, Amarin, Amarin, Atriva, Candel, Eli Lilly, Kane, Landos, Lixte, Oncternal, Orion, Rain, Yumanity.
Read More

Other news to note for April 12, 2021

April 13, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Argenx, Cytokinetics, Fairjourney, Fulcrum, Grunenthal, Hoth, Iontas, Immunos, Lilly, Medigene, Mestex, Mirum, Proteogenix, Pulmatrix, PYC, Sanofi, Santen, Taysha, Valbiotis, Vivet, Zentalis.
Read More
Syringe with Johnson & Johnson logo

Rare clotting cases prompt FDA, CDC to pause rollout of J&J COVID-19 vaccine

April 13, 2021
By Cormac Sheridan
The FDA and the CDC have jointly recommended a temporary pause in the further rollout of Johnson & Johnson Co.’s COVID-19 vaccine while they investigate six rare clotting cases in adults ages 18 to 48.
Read More
Previous 1 2 … 1645 1646 1647 1648 1649 1650 1651 1652 1653 … 9088 9089 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 6, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • DNA, dollars illustration

    Latus Bio series A financing supports early-stage programs

    BioWorld Science

    Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...

  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing